An Experience with Cuban Biotech's Nasalferon to Prevent SARS-COV-2 Infections in International Travelers and their Contacts

MEDICC Rev. 2021 Apr;23(2):10. doi: 10.37757/MR2021.V23.N2.1. Epub 2021 Apr 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Intranasal
  • Antiviral Agents / administration & dosage*
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • COVID-19 Testing
  • Cuba / epidemiology
  • Humans
  • Interferon alpha-2 / administration & dosage*
  • Pandemics
  • SARS-CoV-2
  • Travel*
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Interferon alpha-2